First Time Loading...

Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT

Watchlist Manager
Arcturus Therapeutics Holdings Inc Logo
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Watchlist
Price: 26.55 USD 1.45% Market Closed
Updated: Apr 27, 2024

Arcturus Therapeutics Holdings Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Arcturus Therapeutics Holdings Inc
Net Income (Common) Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Net Income (Common)
-$29.7m
CAGR 3-Years
26%
CAGR 5-Years
-6%
CAGR 10-Years
-11%
Abbvie Inc
NYSE:ABBV
Net Income (Common)
$4.8B
CAGR 3-Years
2%
CAGR 5-Years
-3%
CAGR 10-Years
2%
Gilead Sciences Inc
NASDAQ:GILD
Net Income (Common)
$5.7B
CAGR 3-Years
258%
CAGR 5-Years
1%
CAGR 10-Years
6%
Amgen Inc
NASDAQ:AMGN
Net Income (Common)
$6.7B
CAGR 3-Years
-3%
CAGR 5-Years
-4%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Income (Common)
$3.6B
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Income (Common)
$4B
CAGR 3-Years
4%
CAGR 5-Years
10%
CAGR 10-Years
25%

See Also

What is Arcturus Therapeutics Holdings Inc's Net Income (Common)?
Net Income (Common)
-29.7m USD

Based on the financial report for Dec 31, 2023, Arcturus Therapeutics Holdings Inc's Net Income (Common) amounts to -29.7m USD.

What is Arcturus Therapeutics Holdings Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-11%

The average annual Net Income (Common) growth rates for Arcturus Therapeutics Holdings Inc have been 26% over the past three years , -6% over the past five years , and -11% over the past ten years .